135 related articles for article (PubMed ID: 38706090)
1. Pseudotumor Cerebri Secondary to All-Trans Retinoic Acid/Arsenic Trioxide Therapy in Acute Promyelocytic Leukemia: A Case Report and Review of the Literature.
Mani X; Danesh-Meyer HV
J Neuroophthalmol; 2024 May; ():. PubMed ID: 38706090
[No Abstract] [Full Text] [Related]
2. High pseudotumor cerebri incidence in tretinoin and arsenic treated acute promyelocytic leukemia and the role of topiramate after acetazolamide failure.
Smith MB; Griffiths EA; Thompson JE; Wang ES; Wetzler M; Freyer CW
Leuk Res Rep; 2014; 3(2):62-6. PubMed ID: 25180154
[TBL] [Abstract][Full Text] [Related]
3. All-trans-retinoic acid-induced pseudotumor cerebri in acute promyelocytic leukemia.
Anoop TM; Jain N; Nair SG; Narayanan G
J Neurosci Rural Pract; 2014 Jul; 5(3):273-5. PubMed ID: 25002770
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group.
Adès L; Thomas X; Bresler AG; Raffoux E; Spertini O; Vey N; Marchand T; Récher C; Pigneux A; Girault S; Deconinck E; Gardin C; Tournilhac O; Lambert JF; Chevallier P; de Botton S; Lejeune J; Dombret H; Chevret S; Fenaux P
Haematologica; 2018 Dec; 103(12):2033-2039. PubMed ID: 30026341
[TBL] [Abstract][Full Text] [Related]
5. Pseudotumor cerebri presenting with visual failure in promyelocytic leukemia: a case report.
Rasul FT; Toma AK; Khan AA; Plant GT; Watkins LD
J Med Case Rep; 2012 Nov; 6():408. PubMed ID: 23194090
[TBL] [Abstract][Full Text] [Related]
6. Two successful deliveries of healthy children by a young woman diagnosed and treated during induction and relapsed therapy for acute promyelocytic leukemia.
Dang CC; Guan YK; Lau NS; Chan SY
J Oncol Pharm Pract; 2020 Dec; 26(8):2034-2037. PubMed ID: 32279594
[TBL] [Abstract][Full Text] [Related]
7. Tocotrienols-enriched Self-nanoemulsifying Drug Delivery System Enhances the Antileukemic Activity of All-trans Retinoic Acid but not Electrocardiogram Alterations Evoked by Its Combination with Arsenic Trioxide.
Borges GSM; Sicard P; de Mello Gomides Loures C; Evangelista FGC; Sales CC; de Paula Sabino A; Fernandes C; Ferreira LAM; Richard S
AAPS PharmSciTech; 2023 Mar; 24(3):79. PubMed ID: 36918482
[TBL] [Abstract][Full Text] [Related]
8. Pseudotumor cerebri caused by all-trans-retinoic acid: a case report.
Tiamkao S; Sirijirachai C
J Med Assoc Thai; 2000 Nov; 83(11):1420-3. PubMed ID: 11215876
[TBL] [Abstract][Full Text] [Related]
9. [Effects of combination therapy with all-trans retinoic acid and arsenic trioxide on acute promyelocytic leukemia].
Zhang GC; Zheng D; Li QH; Luo SK; Li J; Peng AH; Tong XZ; Tan EX; Hong WD
Ai Zheng; 2004 Apr; 23(4):430-4. PubMed ID: 15087033
[TBL] [Abstract][Full Text] [Related]
10. Addition of Arsenic Trioxide into Induction Regimens Could Not Accelerate Recovery of Abnormality of Coagulation and Fibrinolysis in Patients with Acute Promyelocytic Leukemia.
Zhang Y; Wu S; Luo D; Zhou J; Li D
PLoS One; 2016; 11(1):e0147545. PubMed ID: 26812490
[TBL] [Abstract][Full Text] [Related]
11. All-trans-retinoic acid and pseudotumor cerebri in a young adult with acute promyelocytic leukemia: a possible disease association.
Visani G; Bontempo G; Manfroi S; Pazzaglia A; D'Alessandro R; Tura S
Haematologica; 1996; 81(2):152-4. PubMed ID: 8641645
[TBL] [Abstract][Full Text] [Related]
12. Severe Wernicke encephalopathy and acute pancreatitis due to all-trans-retinoic acid and arsenic trioxide during treatment of acute promyelocytic leukaemia: a case report.
Jiang Y; Ji L
J Int Med Res; 2020 Sep; 48(9):300060520959487. PubMed ID: 32993392
[TBL] [Abstract][Full Text] [Related]
13. Pseudotumor cerebri in a patient with acute promyelocytic leukemia during treatment with all-trans retinoic acid.
Sano F; Tsuji K; Kunika N; Takeuchi T; Oyama K; Hasegawa S; Koike M; Takahashi M; Ishida M
Intern Med; 1998 Jun; 37(6):546-9. PubMed ID: 9678691
[TBL] [Abstract][Full Text] [Related]
14. Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial.
Zhu HH; Wu DP; Du X; Zhang X; Liu L; Ma J; Shao ZH; Ren HY; Hu JD; Xu KL; Wang JW; Song YP; Fang MY; Li J; Yan XY; Huang XJ
Lancet Oncol; 2018 Jul; 19(7):871-879. PubMed ID: 29884593
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and the Adverse Effects of Oral Versus Intravenous Arsenic for Acute Promyelocytic Leukemia: A Meta-Analysis of Randomized-Controlled Studies.
Sasijareonrat N; Jahn N; Ungprasert P; Owattanapanich W
Technol Cancer Res Treat; 2020; 19():1533033820937008. PubMed ID: 32583728
[TBL] [Abstract][Full Text] [Related]
16. All-trans-retinoic acid and pseudotumor cerebri.
Visani G; Manfroi S; Tosi P; Martinelli G
Leuk Lymphoma; 1996 Nov; 23(5-6):437-42. PubMed ID: 9031073
[TBL] [Abstract][Full Text] [Related]
17. Pseudotumour Cerebri Induced by All-Trans Retinoic Acid: A Case Report.
Ramburuth V; Khalil L
Cureus; 2023 Nov; 15(11):e48520. PubMed ID: 38073920
[TBL] [Abstract][Full Text] [Related]
18. [All-trans retinoic acid/arsenic trioxide combination therapy for a patient with acute promyelocytic leukemia on dialysis].
Nagao R; Hosoba R; Yahagi Y; Gunji T; Uryu H; Hattori D; Momoki M; Yamazaki H
Rinsho Ketsueki; 2019; 60(10):1431-1435. PubMed ID: 31695003
[TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
Burnett AK; Russell NH; Hills RK; Bowen D; Kell J; Knapper S; Morgan YG; Lok J; Grech A; Jones G; Khwaja A; Friis L; McMullin MF; Hunter A; Clark RE; Grimwade D;
Lancet Oncol; 2015 Oct; 16(13):1295-305. PubMed ID: 26384238
[TBL] [Abstract][Full Text] [Related]
20. Acute Promyelocytic Leukemia and Brugada Syndrome: A Report on the Safety of Arsenic Trioxide/All-Trans-Retinoic Acid Therapy.
Rosati G; Camerlo S; Dalmazzo M; Padrini M; Busana TT; De Gobbi M; Fornari A; Morotti A
Hematol Rep; 2023 Jul; 15(3):440-447. PubMed ID: 37489375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
